News|Articles|June 22, 2026

Faricimab (Vabysmo® , Roche Products Ltd) for visual impairment due to macular oedema secondary to retinal vein occlusion: An educational supplement

This is a promotional supplement commissioned by Roche Products Limited.


Latest CME